| Analysis | Metabolite Name | Measured Value | Units | Sample | TREATMENT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.748 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.7641 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.8149 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.8368 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.8446 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.8884 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.9235 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.9278 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.9472 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.9505 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.971 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.9866 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.0134 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.069 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.0859 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.1235 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.1403 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.1815 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.2005 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.3163 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.3457 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.3954 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.4902 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.6081 | Peak area | Plasma | Saline |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|